184 results
Early Breast Cancer - Management Algorithm

#breast #cancer #malignancy #algorithm #oncology #early
Early Breast Cancer ... - Management Algorithm ... #breast #cancer ... #malignancy #algorithm ... #oncology #early
Most Common Breast Masses - Comparison between Fibroadenoma, Cysts and Cancer

#Diagnosis #Oncology #Breast #Masses #Comparison #Table
Most Common Breast ... Masses - Comparison ... and Cancer #Diagnosis ... #Oncology #Breast ... #Masses #Comparison
Breast Mass - Diagnostic Workup Algorithm (Younger than 30)

- BWH Medicine Chiefs @BrighamChiefs

#Breast #Mass #Diagnosis #Workup
Breast Mass - Diagnostic ... Workup Algorithm ... #Mass #Diagnosis ... #Workup #Algorithm ... #Young #oncology
Early Breast Cancer - Management Algorithm
 • Luminal A-like (ER+ and/or PR+, HER2- and low proliferation)
Early Breast Cancer ... - Management Algorithm ... #Cancer #Management ... #Algorithm #treatment ... #oncology
Pulmonary Hypertension Algorithm - Matthew Watto, MD
#Diagnosis #Management #Pulmonary #Hypertension #PAH #Workup #Evaluation #Algorithm #Differential #Curbsiders
Pulmonary Hypertension ... Algorithm - Matthew ... Watto, MD #Diagnosis ... #Management #Pulmonary ... Workup #Evaluation #Algorithm
Lung Ultrasound: Cardiogenic Pulmonary Edema vs ARDS
Cardiogenic Pulmonary Edema:
 • Smooth pleural line
 • AIS >
ARDS Cardiogenic Pulmonary ... Areas of sparing ... UAlberta_Sono #APE ... #edema #comparison ... #clinical #diagnosis
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... = pulmonary embolism ... Malignancy #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
POCUS Lung Algorithm for the Use of Ultrasound in the Evaluation of Dyspnea 

#Diagnosis #Management #CriticalCare
POCUS Lung Algorithm ... of Dyspnea #Diagnosis ... #Management #CriticalCare ... POCUS #Dyspnea #Algorithm ... #Ddxof #Lung #Pulmonary
Multiple Myeloma - Treatment Algorithm
a) Newly Diagnosed Myeloma: Transplant Eligible
b) Newly Diagnosed Myeloma: Transplant Ineligible

doi: 10.1038/s41408-020-00359-2

#Multiple
Myeloma - Treatment Algorithm ... a) Newly Diagnosed ... Eligible b) Newly Diagnosed ... #management #hematology ... #oncology
Who to test for BRCA 1/2?
Female Breast Cancer:
 • ≤ 45-50 years at diagnosis
 • Triple
45-50 years at diagnosis ... years • Any age ... cancer at age 50 ... #indications #oncology ... #screening #diagnosis